Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Oncology Reports|September 25, 2008
Expression of EGFR and follicular dendritic markers in lymphoid follicles from patients with Castleman's diseaseJuhie Lee, Ju Yeon Ban, Kyu Yeoun Won, et al.
Pathology, Research and Practice|September 28, 2013
Tumoral FOXP3 has potential oncogenic function in conjunction with the p53 tumor suppressor protein and infiltrated Tregs in human breast carcinomasKyu Yeoun Won, Hyun-Soo Kim, Ji-Youn Sung, et al.
International Journal of Clinical and Experimental Pathology|January 30, 2016
Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathwayJung-Ho Suh, Kyu Yeoun Won, Gou Young Kim, et al.
Journal of Gastroenterology and Hepatology|October 15, 2014
Amelioration of trinitrobenzene sulfonic acid-induced colitis in mice by liquiritigeninJoon Ki Min, Chi Hoon Lee, Se-Eun Jang, et al.
Frontiers in Immunology|November 29, 2018
Inflammasome-Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal InjurySu-Mi Kim, Yang Gyun Kim, Dong-Jin Kim, et al.
Nephron. Experimental Nephrology|January 12, 2013
Reducing serum uric acid attenuates TGF-β1-induced profibrogenic progression in type 2 diabetic nephropathySu-Mi Kim, Young-Wook Choi, Hwa-Young Seok, et al.
The Korean Journal of Internal Medicine|February 1, 2017
Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF ratsYoo-Cheol Hwang, Da-Hee Oh, Moon Chan Choi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 9, 2012
Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancerSeo-Yun Tong, Jong-Min Lee, Kyung-Do Ki, et al.
International Journal of Clinical and Experimental Pathology|December 1, 2015
High DBC1 (CCAR2) expression in gallbladder carcinoma is associated with favorable clinicopathological factorsKyu Yeoun Won, Hyuck Cho, Gou Young Kim, et al.
Renal Failure|July 29, 2010
Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney modelSul-Ra Lee, Sang-Ho Lee, Ju-Young Moon, et al.
Pageof 10